NanoEcho
0,07 SEK
-5,28 %
Mindre end 1K følgere
NANECH
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
-5,28 %
-6,73 %
+21,69 %
-20,97 %
-7,31 %
-59,62 %
-
-
-52,86 %
NanoEcho operates in the healthcare sector, with a primary focus on rectal cancer diagnostics. The company is currently in the clinical stage, developing a new diagnostic method to determine whether early rectal cancer has spread to nearby lymph nodes. The method aims to provide an accurate diagnosis and personalized treatment. NanoEcho was founded in 2013 and is headquartered in Lund.
Læs mereMarkedsværdi
21,53 mio. SEK
Aktieomsætning
42,17 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
12.2
2026
Årsrapport '25
30.4
2026
Delårsrapport Q1'26
28.5
2026
Generalforsamling '26